Company Overview and News

3
Google Works With Shopify to Spur Commerce, Retail Ad Spending - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SHOP CA GOOGL GOOG

1
Sainsbury shows need for Asda deal as grocery growth slows

2018-07-07 thestar.com.my
J SAINSBURY Plc showed why it’s so eager to lead a consolidation push among the UK’s grocers.
TESO CA JSNSF JSAIY TSCDY TSCDF TSCO

0
Bugs Are Coming Soon to Your Dinner Table

2018-07-05 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CA MTTRY

2
Tesco forms purchasing alliance with Carrefour to cut costs

2018-07-02 thestar.com.my
GENEVA: Tesco Plc is forming a purchasing alliance with French retailer Carrefour SA to increase its leverage with suppliers in a consolidating and price-squeezed supermarket business. The alliance between two of Europe’s largest retailers, with combined annual sales of about $171 billion, will manage purchasing for branded goods and private-label items, the companies said in a joint statement Monday.
OCDDY BOKGY JSAIY TSCDY MTTRY OCDO TESO CA JSNSF BOKGF BOK OCDGF TSCDF TSCO

222
JD.Com Stock Is Back on the Move and Still Undervalued

2018-06-19 investorplace
JD.Com(ADR) (NASDAQ:JD) has started showing signs of a revival. The $550 million investment by Alphabet Inc (NASDAQ:GOOGL, NASDAQ:GOOG) serves as the latest sign of this comeback. Although JD stock took a massive hit over the last four months, the equity has enjoyed a tremendous comeback in June.
JD BABA AMZN CA GOOGL 0700 GOOG EBAY EBAYL

93
Google to Invest $550 Million in China E-Commerce Site JD - Bloomberg

2018-06-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BABA CA GOOGL GOOG

83
Google to invest US$550 million in Chinese e-commerce giant JD.com

2018-06-18 scmp
Google will invest US$550 million in Chinese e-commerce powerhouse JD.com, part of the US internet giant’s efforts to expand its presence in fast-growing Asian markets and battle rivals including Amazon.com.
BABA CA 0700 9984 SFTBF SFTBY

83
Google invests in Chinese e-commerce giant

2018-06-18 perthnow.com.au
Google will invest $US550 million ($A740m) in Chinese e-commerce powerhouse JD.com, part of the US internet giant's efforts to expand its presence in fast-growing Asian markets and battle rivals including Amazon.com.
BABA CA 0700 9984 SFTBF SFTBY

81
Google to invest $550 million in Chinese e-commerce giant JD.com

2018-06-18 reuters
SINGAPORE (Reuters) - Google will invest $550 million in Chinese e-commerce powerhouse JD.com (JD.O), part of the U.S. internet giant’s efforts to expand its presence in fast-growing Asian markets and battle rivals including Amazon.com (AMZN.O).
BABA CA 9984 SFTBF SFTBY

0
Carrefour, Google sign online shopping tie-up in France - Channel NewsAsia

2018-06-11 channelnewsasia
France's largest food retailer Carrefour is partnering with Alphabet 's Google to make groceries available on the U.S. search engine's dedicated shopping site or through voice-assisted devices, the companies said on Monday.
CA

0
Carrefour, Google sign online shopping tie-up in France

2018-06-11 reuters
PARIS (Reuters) - France’s largest food retailer Carrefour (CARR.PA) is partnering with Alphabet (GOOGL.O)’s Google to make groceries available on the U.S. search engine’s dedicated shopping site or through voice-assisted devices, the companies said on Monday.
CA

0
Walmart sells majority of Brazil unit, takes US$4.5 billion charge

2018-06-04 channelnewsasia
NEW YORK/SAO PAULO: Walmart Inc said on Monday that it has sold an 80 percent stake in its Brazilian operations to private equity firm Advent International, exiting an underperforming business in its third major international deal since April.
CA JSNSF JSAIY

366
Alibaba’s Dominance Spooks Would-Be JD.Com Inc Stock Investors

2018-05-30 investorplace
They call the market battle between JD.Com Inc (ADR) (NASDAQ:JD) and Alibaba Group Holding Inc (NASDAQ:BABA) the “great cat and dog war” because of their mascots, JD.Com using a metal dog and Alibaba a cartoon cat. Really, though, JD stock isn’t that competitive.
JD BABA AMZN CA 0700 AAPL WMT

165
Down $82 Billion in Value, Tencent Faces Worst Margins on Record - Bloomberg

2018-05-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA DB C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B BABA CA C.PRPCL CGBBW C.WS.A 0700 C.PRP C.PRU C.PRS

0
Carrefour Brasil launches drive-thru service amid e-commerce push

2018-05-10 reuters
SAO PAULO, May 10 (Reuters) - Carrefour Brasil, the country’s largest food retailer, launched a new click-and-collect style service in Sao Paulo on Thursday, as the company keeps up its recent focus on e-commerce.
CGUIF CA CGUSY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...